好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Therapy of Neuromuscular Disease

Thursday 04/14/11
12:00 PM - 02:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Carlayne E. Jackson, MD, FAAN
Participants should be familiar with current recommended treatment approaches to selected peripheral neuropathies, neuromuscular junction disorders, and motor neuron diseases based on available evidence in the literature as well as expert opinion.
No CME available
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Trainee, General Neurologist, Specialist Neurologist
Case-based, Audience Participation
Event Timeline
12:00 PM - 12:40 PM Amyotrophic Lateral Sclerosis: How to Treat the "Untreatable"
Carlayne E. Jackson, MD, FAAN
12:00 PM - 02:00 PM Break
12:40 PM - 01:20 PM Peripheral Neuropathy: Update in Effective Therapies
Patrick M. Grogan, MD, FAAN
01:20 PM - 02:00 PM Myasthenia Gravis: Treatment Options–Issues and (Some) Answers
John T. Kissel, MD, FAAN
Faculty Disclosures
Carlayne E. Jackson, MD, FAAN Dr. Jackson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma America. Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for AAN. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital.
Patrick M. Grogan, MD, FAAN No disclosure on file
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.